Core Viewpoint - The company is strategically investing in high-performance superconducting materials to support the development of controlled nuclear fusion and high-temperature superconductors, aiming to break foreign technology monopolies and ensure the self-sufficiency of critical materials in China [1][2][3] Group 1: Investment and Partnership - On December 18, 2025, the company announced its investment in Beijing Critical Field Technology Co., Ltd., focusing on upstream key materials for the superconducting industry [1] - The company acquired a 22.50% stake in Beijing Critical Field through a capital increase of RMB 27 million, while another partner, Qingke Chuanglian, acquired a 2.50% stake for RMB 3 million [2] - The registered capital of Beijing Critical Field increased from RMB 4 million to RMB 5.3333 million following this investment [2] Group 2: Technological and Market Implications - The core team of Beijing Critical Field has over 30 years of experience in high-temperature superconducting material research and has participated in significant national projects, holding over 30 patents [1] - The investment aligns with China's "14th Five-Year Plan" for nuclear fusion and aims to capitalize on the commercialization wave in the energy sector, emphasizing the importance of superconducting and key metal materials for the stability and efficiency of fusion devices [2] - The company aims to leverage its expertise in electronic-grade films and polymer composites to synergize with Beijing Critical Field's technological advantages, facilitating a transition into the nuclear fusion materials sector and enhancing its competitive edge [3]
洁美科技投资参股北京临界领域 切入可控核聚变及高温超导材料核心领域